Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49 Convent Drive, Bethesda, MD 20892, USA.
Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, 49 Convent Dr., Bethesda, MD 20814, USA.
Biosensors (Basel). 2024 Oct 7;14(10):481. doi: 10.3390/bios14100481.
Poor placental development and placental defects can lead to adverse pregnancy outcomes such as pre-eclampsia, fetal growth restriction, and stillbirth. This study introduces two sensors, which use a near-infrared spectroscopy (NIRS) technique to measure placental oxygen saturation transabdominally. The first one, an NIRS sensor, is a wearable device consisting of multiple NIRS channels. The second one, a Multimodal sensor, which is an upgraded version of the NIRS sensor, is a wireless and wearable device, integrating a motion sensor and multiple NIRS channels. A pilot clinical study was conducted to assess the feasibility of the two sensors in measuring transabdominal placental oxygenation in 36 pregnant women (n = 12 for the NIRS sensor and n = 24 for the Multimodal sensor). Among these subjects, 4 participants had an uncomplicated pregnancy, and 32 patients had either maternal pre-existing conditions/complications, neonatal complications, and/or placental pathologic abnormalities. The study results indicate that the patients with maternal complicated conditions (69.5 ± 5.4%), placental pathologic abnormalities (69.4 ± 4.9%), and neonatal complications (68.0 ± 5.1%) had statistically significantly lower transabdominal placental oxygenation levels than those with an uncomplicated pregnancy (76.0 ± 4.4%) ( (3,104) = 6.6, = 0.0004). Additionally, this study shows the capability of the Multimodal sensor in detecting the maternal heart rate and respiratory rate, fetal movements, and uterine contractions. These findings demonstrate the feasibility of the two sensors in the real-time continuous monitoring of transabdominal placental oxygenation to detect at-risk pregnancies and guide timely clinical interventions, thereby improving pregnancy outcomes.
胎盘发育不良和胎盘缺陷可导致不良的妊娠结局,如子痫前期、胎儿生长受限和死胎。本研究介绍了两种传感器,它们使用近红外光谱 (NIRS) 技术经腹部测量胎盘氧饱和度。第一种传感器是一种多通道可穿戴的 NIRS 传感器。第二种传感器是 NIRS 传感器的升级版,即多模态传感器,它是一种无线可穿戴设备,集成了运动传感器和多个 NIRS 通道。进行了一项初步的临床研究,以评估这两种传感器在 36 名孕妇(NIRS 传感器 12 名,多模态传感器 24 名)经腹部测量胎盘氧合的可行性。在这些受试者中,有 4 名孕妇为无并发症妊娠,32 名患者存在母体既往疾病/并发症、新生儿并发症和/或胎盘病理异常。研究结果表明,母体合并症患者(69.5 ± 5.4%)、胎盘病理异常患者(69.4 ± 4.9%)和新生儿并发症患者(68.0 ± 5.1%)的经腹部胎盘氧合水平显著低于无并发症妊娠患者(76.0 ± 4.4%)((3,104) = 6.6, = 0.0004)。此外,本研究还展示了多模态传感器检测母体心率和呼吸率、胎儿运动和子宫收缩的能力。这些发现表明,这两种传感器具有实时连续监测经腹部胎盘氧合的可行性,以检测高危妊娠并指导及时的临床干预,从而改善妊娠结局。